The pathologic process of AD with amyloid-beta (Aβ) and tau deposition in the brain begins 10–20 years before the onset of symptoms [7] and can be diagnosed by the presence of amyloid plaques and tau neurofibrillary tangles in the brain and reliably in patients by biomarkers [8,9]. This evidence concerns the gene MAPT and amyloidosis.